HOME
ABOUT US
CONTACT US
PRIVACY & POLICY
DISCLAIMER
TERMS & CONDITIONS
SITE_MAP
Refractory disease
Image Source-Google | Image by- |
genebase
For recurrent high-grade glioblastoma, recent studies have taken gain of angiogenic blockers consisting of bevacizumab in combination with conventional chemotherapy, with encouraging effects.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment